His extraordinary “stock-picking GPS” strategy found Apple at $1.49.

Now it’s flashing STRONG BUY again...

Wed, September 30 at 4:00PM ET
 
 
 
 

10 Biotechnology Stocks to Buy Now

10 Biotechnology Stocks to Buy Now

The grades of 10 Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

This is a strong week for Amgen Inc. (AMGN). The company’s rating climbs to B from the previous week’s C. Amgen Inc. discovers, develops, manufactures, and markets medicines for serious illnesses. The company also gets A’s in return on equity. For more information, get Portfolio Grader’s complete analysis of AMGN stock.

China Biologic Products, Inc. (CBPO) shows solid improvement this week. The company’s rating rises from a C to a B. China Biologic Products, Inc. is a biopharmaceutical company that engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. The company also gets A’s in return on equity. For more information, get Portfolio Grader’s complete analysis of CBPO stock.

Ophthotech Corp. (OPHT) is seeing ratings go up from a C last week to a B this week. The company also gets A’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of OPHT stock.

Xencor, Inc. (XNCR) boosts its rating from a C to a B this week. The company also gets A’s in sales growth, earnings momentum, and return on equity. For more information, get Portfolio Grader’s complete analysis of XNCR stock.

Vitae Pharmaceuticals, Inc. (VTAE) earns a B this week, jumping up from last week’s grade of C. The company also gets A’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of VTAE stock.

Ironwood Pharmaceuticals, Inc. Class A (IRWD) improves from a C to a B rating this week. Ironwood Pharmaceuticals, Inc. Class A discovers, develops, manufactures, and commercializes marketed drugs. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of IRWD stock.

Raptor Pharmaceutical Corp. (RPTP) gets a higher grade this week, advancing from a D last week to a B. Raptor Pharmaceutical Corp. researches existing drugs to improve them through specialized drug targeting methods and formulation changes. The company also gets A’s in sales growth and earnings revisions. For more information, get Portfolio Grader’s complete analysis of RPTP stock.

The rating of MediciNova, Inc. (MNOV) moves up this week, rising from a B to a A. MediciNova, Inc. acquires, develops, and commercializes small molecule therapeutics. For more information, get Portfolio Grader’s complete analysis of MNOV stock.

This week, Venaxis, Inc.’s (APPY) ratings are up from a C last week to a B. Venaxis, Inc. develops and commercializes products for unmet diagnostic and therapeutic needs. For more information, get Portfolio Grader’s complete analysis of APPY stock.

This week, Immunomedics, Inc. (IMMU) pushes up from a C to a B rating. Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. For more information, get Portfolio Grader’s complete analysis of IMMU stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/09/10-biotechnology-stocks-to-buy-now-3/.

©2020 InvestorPlace Media, LLC